Bellerophon Therapeutics Inc (NASDAQ:BLPH)
| 11.85 Delayed Data As of Aug 14 |  -0.40 / -3.27%Today’s Change | 3.19 Today|||52-Week Range 26.00 | +125.91% Year-to-Date |
Latest BLPH News | Press Releases
No recent news for Bellerophon Therapeutics Inc.
Today’s Trading
| Previous close | 12.25 |
| Today’s open | 11.99 |
| Day’s range | 11.85 - 12.08 |
| Volume | 1,673 |
| Average volume (3 months) | 263,383 |
| Market cap | $116.1M |
Data as of 3:59pm ET, 08/14/2020
Growth & Valuation
| Earnings growth (last year) | -500.98% |
| Earnings growth (this year) | -11.41% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 15.59 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZSANZosano Pharma Corp | +0.28 | +20.59% |
| CRVSCorvus Pharmaceutica... | +0.37 | +10.05% |
| ZYNEZynerba Pharmaceutic... | -0.17 | -4.33% |
| QLGNQualigen Therapeutic... | +0.07 | +1.39% |
Data as of 5:56pm ET, 08/14/2020
Financials
| Next reporting date | November 10, 2020 |
| EPS forecast (this quarter) | -$0.75 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$13.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Warren, New Jersey |
Forecasts
